These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Real-world utilization patterns of intravenous immunoglobulin in adults with generalized myasthenia gravis in the United States. Qi CZ; Hughes T; Gelinas D; Li Y; Goyal A; Brauer E; Bhuwalka A; Sato M; Jadhav S; Phillips G J Neurol Sci; 2022 Dec; 443():120480. PubMed ID: 36347174 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin as treatment for myasthenia gravis: current evidence and outcomes. Alabdali M; Barnett C; Katzberg H; Breiner A; Bril V Expert Rev Clin Immunol; 2014 Dec; 10(12):1659-65. PubMed ID: 25331319 [TBL] [Abstract][Full Text] [Related]
13. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status. Illa I J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667 [TBL] [Abstract][Full Text] [Related]
15. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin. Gajdos P; Chevret S Ann N Y Acad Sci; 2008; 1132():271-5. PubMed ID: 18096850 [TBL] [Abstract][Full Text] [Related]
16. Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study. Pasnoor M; Bril V; Levine T; Trivedi J; Silvestri NJ; Phadnis M; Katzberg HD; Saperstein DS; Wolfe GI; Herbelin L; Higgs K; Heim AJ; Statland JM; Barohn RJ; Dimachkie MM Eur J Neurol; 2023 May; 30(5):1417-1424. PubMed ID: 36779862 [TBL] [Abstract][Full Text] [Related]
17. Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report. Yanagihashi M; Okamoto R; Morioka H; Sawada M; Matsumoto S; Ikeda T; Kano O BMC Neurol; 2020 Aug; 20(1):319. PubMed ID: 32859168 [TBL] [Abstract][Full Text] [Related]